HAE
Haemonetics CorpCompany with tickers: HAE
CIK
313143
CUSIP
405024100
Shares Outstanding
45,445,983
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,309,055,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| Cost of Revenue | — | ||||
| Gross Profit | $691,548,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| Operating Expenses | $526,665,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| Research & Development | $54,435,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| Operating Income | $164,883,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| Net Income | $117,558,000 | USD | 2024-03-30 | 10-K | 2026-05-20 |
| EPS (Basic) | $2.32 | USD/shares | 2024-03-30 | 10-K | 2026-05-20 |
| EPS (Diluted) | $2.29 | USD/shares | 2024-03-30 | 10-K | 2026-05-20 |